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During infection by diverse viral families, RNA replication occurs on the surface of virally induced cytoplasmic
membranes of cellular origin. How this process is regulated, and which cellular factors are required, has been unclear.
Moreover, the host–pathogen interactions that facilitate the formation of this new compartment might represent
critical determinants of viral pathogenesis, and their elucidation may lead to novel insights into the coordination of
vesicular trafficking events during infection. Here we show that in Drosophila cells, Drosophila C virus remodels the
Golgi apparatus and forms a novel vesicular compartment, on the surface of which viral RNA replication takes place.
Using genome-wide RNA interference screening, we found that this step in the viral lifecycle requires at least two host
encoded pathways: the coat protein complex I (COPI) coatamer and fatty acid biosynthesis. Our results integrate,
clarify, and extend numerous observations concerning the cell biology of viral replication, allowing us to conclude that
the coupling of new cellular membrane formation with the budding of these vesicles from the Golgi apparatus allows
for the regulated generation of this new virogenic organelle, which is essential for viral replication. Additionally,
because these pathways are also limiting in flies and in human cells infected with the related RNA virus poliovirus, they
may represent novel targets for antiviral therapies.
Citation: Cherry S, Kunte A, Wang H, Coyne C, Rawson RB, et al. (2006) COPI activity coupled with fatty acid biosynthesis is required for viral replication. PLoS Pathog 2(10):
e102. DOI: 10.1371/journal.ppat.0020102
Introduction
Viruses, because of their small genome size, are dependent
on a multitude of cellular factors to replicate within their
hosts. Not only do they have to co-opt cellular factors in
order to complete their replication cycle, but also they must
efﬁciently and simultaneously coordinate many steps of their
replication cycle using host-encoded machinery. This can
require complicated compartmentalization of various steps
in their lifecycle. For example, single-strand RNA viruses
must simultaneously coordinate transcription, RNA replica-
tion, and RNA packaging activities using the same genomic
RNA template.
One example of subcellular separation of these activities is
the observation that all positive-strand RNA viruses, a group
that includes poliovirus, undergo RNA replication in associ-
ation with membranes of infected cells [1]. Depending on the
speciﬁc virus, these membranes can be derived from a variety
of sources within the host cell, including the endoplasmic
reticulum (ER), Golgi apparatus, mitochondria, chloroplasts,
or from the endolysosomal compartment [2]. While the
purpose of this compartmentalization has not been deﬁni-
tively established, several models have been discussed. One
model suggests that this process provides a structural frame-
work for replication, ﬁxing the RNA replication machinery
onto a conﬁned two-dimensional space [3]. This compart-
mentalization of RNA replication may be important due to
the fact that the viral RNA must be used for competing
enzymatic activities: replication and transcription must both
access templates using different machines. The separation of
RNA templates into deﬁned compartments may prevent
interference between these processes. Another model postu-
lates that the compartment may be generated by a cellular
autophagic process. This may allow for the nonlytic release of
virions [4], which in vivo could allow the virus to circumvent
presentation by the immune system. Another possibility is
that autophagy may play an antiviral role in clearing the
cytoplasm of infectious virus. Therefore, the purpose of this
targeted localization has yet to be understood.
Poliovirus, and picornaviridae in general (nonenveloped,
positive-strand RNA viruses), do not use native organelle
membranes for replication but instead actively induce the
formation of a novel cytoplasmic vesicular compartment in
infected cells [5,6]. During replication of these viruses, there
is a massive rearrangement of intracellular membranes
whereby the cytoplasm of the cell becomes densely packed
with vesicles of nonuniform size [7]. Immunoelectron micro-
scopy has revealed that the cytoplasmic surfaces of these
vesicles are the sites of viral RNA replication and that a
membrane compartment is essential for replication [8]. The
mechanisms whereby these viruses induce this vesicular
compartment and direct their RNA replication complex to
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components involved in this process, are not established.
Previous studies have implicated a number of different
trafﬁcking processes including coat protein complex I
(COPI), COPII, and autophagy-mediated processes, with the
membrane being derived from the ER via a COPII coatamer–
mediated process or the Golgi via either COPI or autophagic
vesicles [4,9–12]. Studies investigating how picorna and
related viruses induce the formation of cellular membranes
have used small molecule inhibitors such as Brefeldin A,
which have pleiotropic effects, or have used steady-state
localization experiments that are complicated by the fact that
markers from many different intracellular organelles can be
found residing on virus-induced membranes, making it
difﬁcult to assign a speciﬁc role for speciﬁc cellular
components in the ontogeny of the vesicles.
To overcome some of these limitations, we used a genome-
wide loss-of-function analysis to identify factors required for
the generation of this compartment and viral RNA repli-
cation. To accomplish this, we studied Drosophila C virus
(DCV), a natural pathogen of Drosophila that readily infects
the cells and animals [13]. DCV is a dicistrovirus that is in
many ways similar to picornaviruses such as poliovirus. Both
are encoded by a single positive-strand RNA genome, with a
genome-linked protein at the 59 end and a poly adenosine tail
at the 39 end [14–16]. They also share many physical and
morphological properties of the viral structural proteins
including the requirement for virally encoded proteases for
processing [17,18]. In addition, they are translated by a
specialized, cap-independent, internal ribosome entry site
(IRES) mechanism [19].
Using this Drosophila system allowed us to apply forward
genetics to both the whole organism and cell culture to screen
for host-encoded factors whose loss blocks viral replication.
Recently, we conducted a genome-wide RNA interference
(RNAi) screen and found over 100 genes required for efﬁcient
viral replication in tissue culture [20]. We have begun to
validate the importance of these genes for virus replication
by several approaches and to determine the stage in the viral
lifecycle affected by the loss of each. Using this loss-of-
function strategy, we found that DCV, like mammalian
picornaviruses, induces a cytoplasmic vesicular compartment
upon which viral RNA replication takes place. The formation
of this structure was dependent on the cellular activity of
COPI along with the generation of new membrane by the
fatty acid biosynthetic pathway. Together, these host-encoded
genes drive the formation of these vesicles for viral RNA
replication. Moreover, animals mutant for fatty acid biosyn-
thesis were attenuated for viral replication demonstrating
that this pathway is required and limiting for infection both
in vivo and in vitro. Importantly, we also found that COPI,
but not COPII, was also required for poliovirus infection of
human cells, demonstrating the generality of our ﬁndings.
Results
Gene Ontology Analysis Reveals Overrepresented Cellular
Functions Necessary for Viral Replication
Genome-wide RNAi screening in Drosophila cells using high-
throughput imaging identiﬁed 66 ribosomal proteins and 45
nonribosomal genes as required for DCV replication [20]. In
our ﬁrst study, we showed that knock-down of these
ribosomal proteins blocked translation of IRES-containing
viruses, including poliovirus, due to a requirement for higher
levels of ribosomal function than for host messages, showing a
unique sensitivity of this class of viruses to ribosome
attenuation [20]. To identify roles for the remaining genes
in viral replication, we analyzed Gene Ontology (GO)
associations of the 45 nonribosomal genes required for
DCV replication in Drosophila cells. This analysis showed that
these genes fall into a small number of functional categories
(Figure 1A). In addition, Table 1 lists the 45 genes, their
effects on viral replication, GO category, and whether the
double-strand RNA (dsRNA) amplicons identiﬁed have
potential off-target effects as predicted by 21–base pair
overlaps with other annotated genes. Based on the associa-
tions with Gene Ontology (GO) categories, some biological
processes were signiﬁcantly overrepresented. Speciﬁcally,
statistical analysis revealed that vesicular trafﬁcking processes
were overrepresented while Drosophila-speciﬁc genes were
underrepresented (30% of genome, 4% of set), suggesting
that DCV selectively targets conserved features of the host
cells, and not species-speciﬁc functions.
One notable group of genes within the vesicle trafﬁcking
category included ﬁve of the seven COPI coatamer proteins:
alphaCOP, betaCOP, beta’COP, gammaCOP, and zetaCOP (Figure
1B, p , 0.001 for enrichment relative to representation in the
genome, by Fisher exact test). To conﬁrm that loss of COPI
was responsible for the phenotype and to determine whether
the two COPI genes (deltaCOP and epsilonCOP [CG9543]) not
identiﬁed in the screen were erroneously missed (i.e., false
negatives), we synthesized additional dsRNAs for the seven
COPI coatamer genes and tested them for their role in DCV
replication. These analyses revealed that dsRNAs against all
COPI components except epsilonCOP blocked DCV replica-
tion, although some differences in the extent of the effect
were observed, possibly reﬂecting variability in the efﬁciency
of the gene silencing mediated by the dsRNAs (Figure 1B).
Thus, we can conclude that deltaCOP was a false negative in
the primary screen. However, neither of the dsRNAs directed
against epsilonCOP had an effect on DCV replication. RT-PCR
analysis demonstrated that epsilonCOP mRNA was depleted,
demonstrating that the dsRNA was functional (Figure S1).
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Synopsis
In order to successfully invade and replicate within their hosts,
viruses hijack cellular factors. In the case of many RNA viruses,
including a Drosophila picorna-like virus Drosophila C virus, they
must undergo the essential step of genomic replication on the
surface of cytoplasmic membranes. Specifically, for picornaviruses,
these vesicles are induced in the infected cell, and the ontogeny and
cellular factors required to form this compartment have been
unclear. Circumstantial evidence has implicated coat protein
complex I (COPI), COPII, and autophagy. Here, Cherry and colleagues
present their findings using a genome-wide RNA interference
screening approach using a picorna-like virus that COPI and fatty
acid biosynthesis are critical host pathways required to generate this
intracellular vesicular compartment. Furthermore, they show that
loss of COPI, but not COPII, is protective both in adult flies and in
human cells infected with the related picornavirus, poliovirus. These
novel and exciting findings have broad-scale implications for
picornavirus replication and for the potential use of these pathways
as novel antiviral targets.However, the protein may be long-lived—something we could
not assess due to the absence of antibodies directed against
either this or the other Drosophila COPI proteins. Never-
theless, these data suggest that it may have an unknown
homolog which can substitute for its function. It should be
noted that in yeast only six of the seven coatamer
components are essential—only epsilonCOP is dispensible
[21]. This suggests that epsilonCOP may be dispensable for
COPI function in both yeast and Drosophila.
COPI, but Not Secretion, Is Required for DCV Replication
Two vesicular coat complexes, COPI and COPII, are
required for trafﬁcking between the ER and Golgi [22].
Formation of transport vesicles is dependent on the recruit-
ment of these cytosolic coat proteins to the surface of the
donor compartment membrane from which they bud.
Whereas the COPII coatamer is required for the anterograde
transport of proteins from the ER to the Golgi, the COPI
coatamer is required for retrograde transport of recycled
proteins and membrane from the Golgi to the ER [23].
Blocking either the COPI or the COPII coatamer pathways
blocks protein secretion, as observed in yeast mutants for the
orthologous genes and in studies using RNAi screening for
genes required for general secretion [24]. However, we only
identiﬁed COPI-associated genes and none of the COPII
coatamer components (Sec13, Sec31, Sec23, and Sec24
[CG1472]) in our screen, suggesting that either the COPII
coatamer proteins are refractory to RNAi-mediated deple-
tion in our cells or DCV replication speciﬁcally requires
COPI function but not COPII.
Figure 1. COPI Coatamer Complex Is Required for Viral Replication
(A) Frequency of encoded functional groups as curated by GO (The FlyBase Consortium) and manually assigned to representative categories for all
verified candidates. Categories that are overrepresented with p , 0.05 are indicated.
(B) Decreased viral replication post dsRNA treatment with dsRNA against alphaCOP, betaCOP, beta’COP, gammaCOP, deltaCOP, and zetaCOP as
compared to dsRNA treatment with GFP or epsilonCOP. Images were quantified as the percentage of infected cells (FITC-anti DCV [green]) divided by
(Hoescht 33342 [red]).
DOI: 10.1371/journal.ppat.0020102.g001
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COPI, Fatty Acids, and Viral ReplicationTo rule out a role for COPII in DCV replication, we
modiﬁed a microscopy-based assay to quantitatively monitor
secretion of a plasma membrane reporter protein, Delta, to
test whether the dsRNAs directed against COPII components
were effective [25]. Using Drosophila cells that were stably
transformed with an inducible membrane-bound form of
Delta (DeltaNdeMyc cells [26]), we were able to assess the
effects of different dsRNAs on the secretory pathway using
ﬂow cytometry. We pretreated cells with dsRNAs for 3 d and
then induced the transgene with the addition of copper
Table 1. Nonribosomal Genes Required for DCV Replication
Gene
Name
Identifier DRSC
Amplicons
Unigene
Accession
Numbers
Category Fold-
Decrease
Human
Homolog
Off-Targets
(21 bp)
Off-Targets
(19 bp)
Dp FBgn0011763 DRSC07402 Dm.6412 Cell cycle 1.8 TFDP2 0 0
CycE FBgn0010382 DRSC03296 Dm.3509 Cell cycle 1.4 CCNE1 0 0
cdc2 FBgn0004106 DRSC03504 Dm.3187 Cell cycle 1.4 CDC2 0 0
CG6962 FBgn0037958 DRSC16153 Dm.1159 Conserved
a 2.4 FLJ20297 0 2
Fax FBgn0014163 DRSC11345 Dm.6723 Conserved
a 3.1 C6orf168 0 0
TER94 FBgn0024923 DRSC07560 Dm.2968 Cytoskeleton organization and biogenesis 3.8 VCP 0 1
Map205 FBgn0002645 DRSC16732 Dm.1892 Cytoskeleton organization and biogenesis 4.4 0 1
Tektin-C FBgn0035638 DRSC09741 Dm.5022 Cytoskeleton organization and biogenesis 4.9 TEKT1 0 1
Arpc3B FBgn0030818 DRSC20126 Dm.19161 Cytoskeleton organization and biogenesis 7 0 1
Bgm FBgn0027348 DRSC03495 Dm.20327 Fatty acid metabolism 1.6 BGR 0 1
CG11198 FBgn0033246 DRSC07249 Dm.11366 Fatty acid metabolism 7.2 ACACA 0 0
CG5844 FBgn0038049 DRSC15890 Dm.1171 Fatty acid metabolism 8.4 0 0
CG3523 FBgn0027571 DRSC00268 Dm.7216 Fatty acid metabolism 10.6 FASN 0 5
HLH106 FBgn0015234 DRSC11182 Dm.7945 Fatty acid metabolism 38.2 SREBF1 0 0
ZetaCOP FBgn0040512 DRSC11412 Dm.20098 Intracellular protein transport 1.8 COPZ1 0 0
GammaCOP FBgn0028968 DRSC16955 Dm.1895 Intracellular protein transport 3.1 COPG 0 0
Rab5 FBgn0014010 DRSC00777 Dm.6724 Intracellular protein transport 3.3 RAB5C 0 2
BetaCop FBgn0008635 DRSC20312 Dm.2883 Intracellular protein transport 3.4 COPB 0 1
AlphaCop FBgn0025725 DRSC08706 Dm.2217 Intracellular protein transport 3.8 COPA 0 0
beta’Cop FBgn0025724 DRSC03492 Dm.2980 Intracellular protein transport 6.5 COPB2 0 1
Rack1 FBgn0020618 DRSC03405 Dm.6830 Intracellular protein transport 11.2 GNB2L1 0 1
CG7835 FBgn0030879 DRSC20058 Dm.3606 Not conserved
b 1.4 14
c 85
c
DRSC01393 DRSC01393 None Not conserved
b 2.8 0 0
DRSC05108 DRSC05108 None Not conserved
b 4.6 2 3
CG4585 FBgn0025335 DRSC04475 Dm.3875 Not conserved
b 5.2 0 0
CG9300 FBgn0036886 DRSC11064 Dm.999 Not conserved
b 8.4 0 0
CG17209 FBgn0030687 DRSC19766 Dm.14839 Nucleobase, nucleoside, nucleotide,
and nucleic acid metabolism
1.7 POLR3A 0 0
Ercc1 FBgn0028434 DRSC07424 None Nucleobase, nucleoside, nucleotide,
and nucleic acid metabolism
1.8 ERCC1 0 0
CG1814 FBgn0033426 DRSC06711 Dm.8006 Nucleobase, nucleoside, nucleotide,
and nucleic acid metabolism
2.8 TU12B1-TY 0 0
CG3436 FBgn0031229 DRSC00605 Dm.1591 Nucleobase, nucleoside, nucleotide,
and nucleic acid metabolism
7.6 HPRP8BP 0 0
Prosalpha7 FBgn0023175 DRSC07516 Dm.2041 Proteolysis and peptidolysis 1.8 PSMA1 0 1
Ubi-p63E FBgn0003943 DRSC22016 Dm.2641 Proteolysis and peptidolysis 3.7 UBC 0 0
CG11700 FBgn0029856 DRSC17794 Dm.26471 Proteolysis and peptidolysis 13.9 UBB 3
d 3
d
Ip259 FBgn0025366 DRSC03352 Dm.4835 Ribosome biogenesis 2.9 TINP1 0 0
cg8801 FBgn0028473 DRSC05954 Dm.6389 Ribosome biogenesis 2.9 GTPBP4 0 0
CG12050 FBgn0032915 DRSC02152 Dm.1478 Ribosome biogenesis 3.5 FLJ12519 0 1
Pit FBgn0025140 DRSC22798 Dm.1273 Ribosome biogenesis 4.8 DDX18 0 0
CG14210 FBgn0031040 DRSC19566 Dm.6071 Ribosome biogenesis 6 MGC2574 1 5
CG5651 FBgn0035946 DRSC10533 Dm.7778 Ribosome biogenesis 12.3 ABCE1 0 0
CG4364 FBgn0032138 DRSC02742 Dm.372 Ribosome biogenesis 2.1 PES1 0 2
Trip1 FBgn0015834 DRSC03464 Dm.23184,
Dm.2654
Translation 2.9 EIF3S2 0 0
eIF-1A FBgn0026250 DRSC16937 Dm.1640 Translation 3.2 EIF1AX 0 0
EIF3-S10 FBgn0037249 DRSC12339 Dm.5844 Translation 6.4 eIF3-S10 0 1
ERF1 FBgn0036974 DRSC11779 Dm.2095 Translation 8 ETF1 0 1
Su(var)3–9 FBgn0003600 DRSC13081 Dm.3299 Translation 26 EIF2S3 0 0
aConserved ¼ has orthologs outside of insects, but does not fit into above GO categories.
bNot conserved ¼ has no ortholog outside of insects.
cLikely has off-target effects.
dThe amplicon has homology to homologs.
Gene name and FlyBase identifier are listed along with GO category. Fold-decrease represents the average decrease in percent infection compared to control treatment. The closest
human homolog is indicated. The number of exact 21-bp targets in the Drosophila genome that are not the intended target.
The off-target genes are homologs of the intended target. Genes listed as conserved have orthologs in Homologene but are not within the GO categories listed. Genes listed as not
conserved do not have orthologs outside of insects in Homologene.
DOI: 10.1371/journal.ppat.0020102.t001
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COPI, Fatty Acids, and Viral Replicationsulfate for 2 h. Cell surface levels of Delta were measured by
staining unpermeabilized cells with an antibody that recog-
nizes extracellular Delta. Using this assay on control cells, we
detected a large increase in surface Delta expression as
compared to uninduced cells (Figure 2A, compare green and
purple). Treatment of the cells with dsRNA against COPI
(betaCOP) or COPII (sec23) components signiﬁcantly decreased
the extracellular levels of Delta as expected (Figure 2A). While
dsRNA treatment against sec23 did not block secretion as
much as knockdown of betaCOP, treatment with dsRNA
against Syntaxin 5 (Syx5), a t-SNARE required at the Golgi
for secretion [27], was able to block secretion to a similar
extent as COPI. Despite this, treatment with dsRNA against
sec23 or Syx5 had no effect on viral replication (unpublished
data). These data suggest that DCV replication does not
require a functional secretory pathway per se but instead
speciﬁcally requires COPI (but not COPII) coatamer function.
COPI Is Required Downstream of Entry
We next sought to determine which step in the viral
lifecycle requires COPI function, and so we ﬁrst determined
whether depletion of COPI by dsRNA treatment affected
D C Ve n t r yi nt i s s u ec u l t u r ec e l l s .W eh a dp r e v i o u s l y
determined that viral entry requires clathrin-mediated
endocytosis and thus did not anticipate a requirement for
COPI during entry. Nevertheless, we tested whether pretreat-
ment with dsRNAs against control (GFP [green ﬂuorescent
protein]), COPI (betaCOP), or COPII (sec23) affected viral
entry. To do this, the cells were pretreated with dsRNAs for 3
d and, then incubated at 4 8C to block endocytosis. Next,
virions were added at a multiplicity of infection of 10 and
allowed to bind to the surface of these dsRNA-treated cells.
After 1 h of binding, the cells were washed to remove
unbound virions and then returned to 25 8Ct oa l l o w
endocytosis to resume. After 3 h, the cells were immunos-
tained to visualize virions during entry through the endocytic
compartment. Using this assay, and quantitation with
automated image analysis, we found that depletion of COPI
(or COPII) did not block viral entry (Figure 2B).
To verify that this assay is sensitive to genes required for
DCV entry, we tested the effect of Rab5, another cellular
factor identiﬁed in our screen. Rab5 encodes a small GTPase
required for endocytosis, and as such should be required for
DCV uptake [28]. Indeed, we found that treatment with Rab5
dsRNA resulted in a 4-fold decrease in viral entry (Figure 2B).
We did not identify other genes involved in clathrin-
mediated endocytosis in this screen, suggesting that genes
such as clathrin may be difﬁcult to deplete in the Drosophila
cell lines used. However, our RNAi screen was able to uncover
a component of the endocytic apparatus required for viral
entry (Rab5) and further underscores the role for COPI as
required for a step in the viral lifecycle postentry.
DCV Induces a Cytoplasmic Vesicular Compartment that Is
the Site of RNA Replication
All positive-strand RNA viruses undergo RNA replication
on the surface of intracellular membranes [1]. Picornaviruses,
which are similar in many respects to DCV, induce the
formation of cytoplasmic vesicles of nonuniform size, and it is
on the surface of these vesicles that viral RNA replication
occurs [5–7]. We used ultrastructural analysis to test whether
DCV might induce a similar vesicular compartment and
found that, indeed, vesicles were induced in the cytoplasm of
infected cells but not in the uninfected control cells (compare
Figure 3A to Figure 3B). While the vesicles were nonuniform
in size, they averaged 115 nm in diameter.
We next determined whether DCV uses these vesicles as a
site for RNA replication. To this end, we generated an
antibody against the DCV helicase, an integral component of
the RNA replication machinery. We stained cells that were
either uninfected or infected with DCV with the anti-helicase
antibody and monitored localization using immunoelectron
microscopy. We found that the DCV helicase was localized to
the surface of these vesicles and did not stain the uninfected
cells (Figure 3F–3G and unpublished data). Greater than 90%
of the gold labeling was vesicle associated, demonstrating that
the RNA replication machinery is indeed compartment
bound. Importantly, the vesicles were detectable by 10 h
postinfection but not at an earlier time point (unpublished
data), consistent with our previous ﬁndings that new viral
protein synthesis begins at approximately 7 h postinfection
[13]. Because these viruses do not encapsidate the RNA
polymerase, RNA replication cannot begin until the genomic
RNA is translated to produce the viral factors required for
RNA replication including the helicase. Altogether, our data
demonstrate that the vesicles form postentry and posttrans-
lation and are the site of RNA replication.
Vesicle Formation Is COPI Dependent
Because DCV induces a cytoplasmic vesicular compartment
and requires the COPI coatamer for replication, we tested
whether this compartment might be generated by the activity
of the COPI complex. If the COPI coatamer directly forms
these vesicles, then this might explain why DCV replication is
dependent on COPI, but not COPII, function. Thus, we tested
whether depletion of COPI affected the formation of DCV-
dependent vesicles by treating cells with dsRNAs against
COPI (betaCOP), COPII (sec23), or a control (GFP) followed by
DCV infection. At 10 h postinfection, both control cells
(Figure 3B) and COPII-treated cells (sec23, Figure 3D) were
densely packed with the newly formed vesicles, despite the
fact that dsRNA against sec23 reduced transport of Delta to
the cell surface. Randomly selected cells were quantitated in
terms of the presence or absence of the characteristic
cytoplasmic vesicles; 87% of control cells and 83% of sec23-
depleted cells were ﬁlled with the vesicles. In contrast, the
COPI-depleted cells had a 2.5-fold reduction in the percent-
age of cells that contained vesicles (34%, Figure 3C),
suggesting that the COPI coatamer is required to generate
this vesicular compartment during DCV replication.
DCV Replication Disrupts the Golgi Apparatus
Since the COPI coatamer normally buds vesicles from the
Golgi apparatus [22,29], we reasoned that the virus-induced
vesicular compartment might be generated by COPI-medi-
ated budding of vesicles from the Golgi during DCV
replication. Although the COPI machinery required for
trafﬁcking is conserved between yeast, mammals, and insects,
there are striking differences in the morphologies of the
Golgi apparatus. In Drosophila, the Golgi cisternae are not
interconnected to form a single copy organelle that is
typically juxtanuclear. Instead, the vesicles are stacked and
dispersed throughout the cytoplasm, as is the case in plants
and yeast [30, 31]. We tested whether the morphology of the
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COPI, Fatty Acids, and Viral ReplicationFigure 2. COPI Is Specifically Required for DCV Replication Postentry
(A) FACS analysis demonstrates that COPI (betaCOP) and COPII (sec23) are required for Delta secretion. DeltaWTNdeMYC cells were treated with dsRNA
and subsequently Delta expression was induced for 2 h. Extracellular Delta expression was monitored by FACS. The bar was set such that 98% of the
total uninduced cells were negative for Delta staining. Induction leads to a shift in the population to express surface Delta, such that only 31% of the
cells remain negative. Under these conditions, COPI, COPII, and SREBP block surface staining.
(B) DCV entry requires endocytosis (Rab5) but not COPI (bCOP) or COPII (sec23) function. Cells were pretreated with dsRNA, infected at 4 8C to allow
surface binding, followed by 3 h at 25 8C to release the block to endocytosis and monitor viral trafficking. Viral uptake was measured by determining the
percentage of cells (red) that contained virus (green). Green, anti-DCV; red, Alexa-fluor-568-phalloidin.
DOI: 10.1371/journal.ppat.0020102.g002
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COPI, Fatty Acids, and Viral ReplicationGolgi was altered during DCV replication by infecting
Drosophila cells with DCV and monitoring the structure of
the Golgi using an antibody to a membrane-bound Golgi
resident protein. Using confocal microscopy, we found, as has
been observed by others, that the Golgi has a punctate
morphology in uninfected Drosophila cells [30,32] (Figure 4A,
uninfected cells). In contrast, the morphology of the Golgi
was altered in the infected cells. The punctae seemed smaller
and increased in number throughout the cytoplasm of the
cell (Figure 4A, infected cells). This disruption resembles the
large number of dispersed vesicles observed by electron
microscopy. These observations were made using two differ-
ent antibodies against the Golgi (anti-Golgi and DG13).
Moreover, we co-stained infected cells with antibodies to
DCV helicase and a Golgi marker (DG13) using immunoelec-
tron microscopy. We found that the DCV-induced vesicles
that are coated by the viral helicase (5-nm gold particles) are
also positive for the Golgi marker (12 nm) (Figure 3H). This
demonstrates that these vesicles are indeed derived from the
Golgi apparatus.
Because Golgi morphology was disrupted by DCV during
replication, and depletion of the COPI coatamer blocked
DCV replication; we reasoned that the Golgi morphology of
COPI-depleted cells might be altered. Indeed, treatment of
cells with dsRNA to COPI (betaCOP) led to a decrease in Golgi
staining (Figure 4B), which was distinct from the change in
Golgi morphology observed upon infection (compare the
signal levels in uninfected cells in Figure 4A and 4B). The
absolute levels of Golgi markers were decreased in COPI-
treated cells, whereas the signal was dispersed in DCV-
infected cells as observed by confocal microscopy. In contrast,
treatment with dsRNA to a ribosomal protein, RpS6, which
blocks DCV translation, and thus replication at a different
step in the lifecycle, had no effect on Golgi morphology
(unpublished data). Moreover, depletion of Syx5 (t-SNARE) or
COPII (sec23) led to a loss in Golgi staining but had no effect
on viral replication (Figure 4C and 4D). This demonstrates
that loss of Golgi per se is not sufﬁcient to block viral
replication. Instead, the speciﬁc loss of COPI results in a loss
of the Golgi, a defect in vesicle formation, and a block in viral
replication. Together, this suggests that the vesicular com-
partment is formed by COPI coatamer-mediated disassembly
from the Golgi during infection and that the Golgi disruption
mediated by the loss of COPII does not block COPI access to
the appropriate target for vesicle formation.
Fatty Acid Biosynthesis Is Required to Generate This
Vesicular Compartment
The apparent requirement for the generation of a COPI-
dependent vesicular compartment for DCV replication led us
Figure 3. Ultrastructural Analysis Reveals Virus-Dependent Vesicular Compartment
(A) Uninfected cells with intact Golgi.
(B) Vesicles were generated at 10 h postinfection throughout the cytoplasm of cells pretreated with dsRNA against GFP and infected with DCV.
(C–E) Cells were pretreated with dsRNA against COPI (bCOP) (C), COPII (sec23) (D), or SREBP (E), infected with DCV, and prepared for electron microscopy.
(F) Immunoelectron microscopy of Drosophila cells infected with DCV and the RNA replication machinery was visualized using anti-DCV helicase and a
secondary antibody coupled to 10-nm gold particles. The surfaces of cytoplasmic vesicles (arrows) are stained.
(G) Higher-magnification view of DCV helicase–labeled vesicle.
(H) Immunoelectron microscopy of Drosophila cells infected with DCV and the RNA replication machinery was visualized using anti-DCV helicase and a
secondary antibody coupled to 5-nm gold particles. The Golgi was visualized using an anti-Golgi antibody (DG13) and a secondary antibody coupled to
12-nm gold particles.
DOI: 10.1371/journal.ppat.0020102.g003
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COPI, Fatty Acids, and Viral Replicationto hypothesize that there might be additional genes identiﬁed
in our genome-wide RNAi screen that might also be required
to generate this vesicular compartment. Therefore, we tested
whether any of the other genes had a phenotypic effect on the
morphology of the Golgi, and thus might be required for the
generation of the vesicular compartment. We screened the 45
genes and found that while the majority had no effect on the
Golgi as monitored by immunoﬂuorescence microscopy, two
additional genes led to a loss in Golgi staining similar to that
seen on treatment with dsRNAs against the COPI coatamer
components. Both of these (HLH106 and CG3523) encode
factors required for fatty acid biosynthesis (Figure 4F and
unpublished data).
HLH106, also known as sterol regulatory element binding
protein (SREBP), is the master transcriptional regulator of
fatty acid metabolism, and directly controls the transcription
of CG3523 which encodes fatty acid synthase, the ﬁrst rate-
limiting enzymatic step in the pathway [33]. These results
indicate that fatty acid biosynthesis is required both for DCV
replication and for maintenance of the Golgi compartment.
Additionally, we found that depletion of these factors had no
effect on viral entry (unpublished data). Instead, depletion of
these factors blocked the formation of the virus-induced
vesicular compartment as measured by electron microscopy
(Figure 3, unpublished data).
Our ﬁnding that fatty acid biosynthesis was required for
the formation of this compartment is consistent with the
observation that infected cells have a net increase in
membrane due to the large number of cytoplasmic vesicles
(2-fold increase in total membrane). Our results are also
supported by the observation that cerulenin, a fatty acid
synthase inhibitor, blocks positive-strand RNA virus (includ-
ing poliovirus) replication in tissue culture [34]. While SREBP
in mammals is cholesterol responsive and as such regulates
both fatty acid metabolism and cholesterol biosynthesis, in
insects SREBP responds to palmitate levels (Drosophila is a
cholesterol auxotroph [35]). Nevertheless, Drosophila SREBP
controls many of the same regulators of fatty acid biosyn-
thesis, suggesting conserved functions in viral replication.
SREBP, COPI, and Fatty Acid Biosynthesis Are Limiting for
Viral Replication in Animals
To test the dependence of DCV infection on host fatty acid
biosynthesis in vivo, we infected Drosophila SREBP mutants
with DCV. SREBP-null adults were generated by rescuing the
larval lethality of the mutation with an RU486-inducible wild-
type SREBP transgene that is expressed exclusively during
larval development [36]. Withdrawal of RU486 results inadults
that do not express the rescue construct and as such are null
for SREBP as measured by Western blot analysis (Figure 5A).
Therefore, SREBP is dispensable in adult ﬂies. We challenged
these mutants or their heterozygous siblings with DCV and
monitored viral replication using two methods. First, we used
immunoblot analysis to monitor viral capsid production as a
function of time postinfection. Consistent with the cell-based
results, SREBP mutant ﬂies had reduced levels of viral antigen
production as compared to heterozygous matched siblings
normalized to cellular tubulin levels (Figure 5B). Second, we
monitored viral RNA production by RT-PCR and found that
lossof SREBP severely attenuated viral replication (Figure 5C).
This demonstrates that the transcriptional master regulator of
fatty acid biosynthesis, SREBP, is required and limiting for
viral replication in animals.
We also found that there was a synthetic interaction
between fatty acid biosynthesis and COPI activity in vivo.
Figure 4. COPI-Dependent Golgi Disassembly in DCV Infected Cells
Confocal analysis of cells pretreated with the indicated dsRNA and infected with DCV.
(A) Golgi morphology of DCV-infected control cells (GFP) reveals that the normal punctate staining in uninfected cells is dispersed during viral
replication.
(B–F) Loss of COPI (bCOP) (B), SREBP (E), or CG3523 (F) but not COPII (sec23) (C) or Syx5 (D) results in a decrease in viral infection. Note that the Golgi stain
is reduced in uninfected COPI, COPII, SREBP, CG2523, and Syx5, but only the loss in COPI, SREBP, or CG3523 results in a decrease in DCV replication.
Green, anti-Golgi (DG13); red, anti-DCV; blue, Hoescht 33342.
DOI: 10.1371/journal.ppat.0020102.g004
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COPI, Fatty Acids, and Viral ReplicationWhile heterozygous mutants of gammaCOP or fatty acid
synthase (CG3523) were unaffected in their ability to support
DCV replication, ﬂies carrying mutant alleles for both
gammaCOP and fatty acid synthase were attenuated in their
ability to support DCV replication as measured by viral
antigen production (Figure S2). Therefore, the pathways that
were limiting in vitro for viral replication were also limiting
in animals.
Poliovirus Infection Is Also Sensitive to Depletion of COPI
but Not COPII
Because attenuation of COPI, but not COPII, blocked DCV
replication, we hypothesized that this effect may be general-
izable to mammalian picornaviruses such as poliovirus. To
test whether attenuation of these pathways protected human
cells from poliovirus replication, we infected human cells
pretreated with small interfering RNAs (siRNAs) against
control, alphaCOP or sec23B with poliovirus. We assayed
infection by immunoﬂuorescence staining of infected cells
using an antibody against VP1, a capsid protein (Figure 6A).
We quantitated these images and observed a signiﬁcant
reduction of viral infection in cells transfected with siRNAs
against alphaCOP as compared to control siRNA or siRNA
against sec23B (Figure 6B). To conﬁrm that the siRNA against
sec23B was functional, we measured the levels of sec23B and
alphaCOP by RT-PCR. We found that treatment with either
sec23B or alphaCOP siRNA led to a depletion of the cognate
mRNA, demonstrating that sec23B is depleted yet is dispen-
sable for poliovirus replication in human cells (Figure 6C).
Therefore, these data suggest that poliovirus replication in
human cells, like DCV replication in Drosophila cells, requires
COPI, while COPII activity is dispensable.
Discussion
In this work, we have shown the dependence of DCV
replication on an array of host-encoded factors. Using an
unbiased loss-of-function screen, we identiﬁed a number of
factors involved in different stages of the viral lifecycle.
Moreover, because this RNAi methodology does not result in
null alleles, but instead in hypomorphic phenotypes, we were
abletoidentifythelimitingcomponentsforviralreplicationin
thecell.Interestingly,thesehostfactorsaresigniﬁcantlybiased
toward conserved genes as opposed to species-speciﬁc factors,
demonstratingthatDCVspeciﬁcally,andperhapsvirusesmore
generally, may selectively target conserved functions in the
cell. This may help explain how some viruses can readily infect
disparate hosts (mosquitoes, humans, etc.) and parsimoniously
expand their range to new species. Moreover, because these
required, but limiting, genes are essential for DCV replication
inDrosophilacells,onemaypresumethatrelatedvirusesmaybe
dependent on similar cellular factors for replication. Indeed,
we conﬁrmed that poliovirus replicationin mammalian cells is
also dependent on COPI.
We found that DCV, like picornaviruses, induces the
formation of a cytoplasmic vesicular compartment in
Figure 5. Attenuation of Fatty Acid Biosynthesis in Animals Is Protective
(A) SREBP-null flies were generated by rescuing the larval lethality using an inducible transgene and have no detectable SREBP protein as adults as
measured by immunoblot probed with anti-SREBP.
(B) These SREBP-null flies are resistant to viral infection as measured by viral antigen production post infection. Heterozygous or homozygous SREBP
mutant flies were challenged with DCV, and viral antigen production was measured as a function of time postinfection. Protein lysates were generated
(hours postinfection indicated [Hr p.i.], normalized, and probed with anti-DCV or anti-tubulin for normalization.
(C) SREBP-null flies are resistant to viral infection as measured by viral RNA production postinfection. Heterozygous or homozygous SREBP mutant flies
were challenged with DCV, and viral RNA production was measured by RT-PCR at the indicated time points postinfection (Hr p.i.).
DOI: 10.1371/journal.ppat.0020102.g005
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COPI, Fatty Acids, and Viral Replicationinfected cells and that this compartment is the site of viral
RNA replication. Among the conserved genes whose dis-
ruption signiﬁcantly reduced DCV replication were a group
of vesicular trafﬁcking genes including the COPI coatamer.
Our data show that COPI was required downstream of viral
entry and was essential for the production of this vesicular
compartment. However, we cannot rule out the possibility
that COPI is required postentry, prevesicle formation for a
step in the viral lifecycle independent of its role in secretion.
In contrast, our data clearly show that both COPII and
autophagy were dispensable for both viral replication and
vesicle formation. For autophagy, we directly tested the roles
of Beclin-1, Atg5, Atg18, and Atg12 and found no defect in
DCV replication (unpublished data). This is important
because there has been much debate on the ontogeny of
vesicles that arise during picornavirus replication. This is due,
at least in part, to the experimental approaches used to
determine the factors involved. For example, it is difﬁcult to
discern cause from effect in studies utilizing marker co-
localization strategies, as many different cellular factors and
compartments may be associated with the vesicles. By
undertaking a loss-of-function study, we were able to identify
speciﬁc factors required to form the vesicular compartment,
rather than simply identifying factors found associated with
the membranous compartment under steady state conditions.
While it is possible that some of the vesicles associated with
viral replication are generated via a COPII or an autophagic
process, our data clearly demonstrate that these latter
processes are not essential for bulk vesicle formation or for
viral replication.
Because the COPI coatamer normally targets and buds from
the Golgi and DCV-induced vesicles required COPI activity,
we analyzed the state of the Golgi during infection. We found
that normal Golgi morphology was disrupted during viral
replication with many small punctae distributed throughout
the cytoplasm of the cell, consistent with the disassembly of
Figure 6. Attenuation of COPI but Not COPII Protects Human Cells from Poliovirus Infection
(A) Poliovirus infection of Caco-2 cells pretransfected with siRNAs against alphaCOP results in inhibition of viral replication but not control siRNA or
siRNA against sec23B as measured by immunofluorescence analysis of infected cells (nuclei [blue] ¼ DAPI, infected cells [green] ¼ FITC-conjugated
mouse anti-enterovirus VP1).
(B) Percent infection (FITC-positive cells/DAPI * 100) is shown for two independent experiments performed in triplicate where error bars represent one
standard deviation. *p , 0.05.
(C) Plaque-forming units/mL (pfu/mL) are shown for the experiments performed in (B). *p , 0.05.
(D) RT-PCR on Caco-2 cells treated with siRNA against alphaCOP or sec23B demonstrates that treatment with either siRNA leads to a significant
depletion of the cellular mRNA and amplification of GAPDH was used as loading control.
DOI: 10.1371/journal.ppat.0020102.g006
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vesicles used for RNA replication. We also demonstrated that
a Golgi marker co-localizes with the RNA replication
machinery at the DCV-induced vesicles. At present, we cannot
determine if this compartment is formed directly by the
conversion of the Golgi into a novel speciﬁc structure or
whether membrane is derived from other cellular structures.
This is in part because an intact Golgi was not required for
vesicle formation, suggesting that the COPI coatamer targets a
speciﬁc membrane component that remains accessible even if
the Golgi is apparently disrupted by the loss of cellular factors
including COPII or Syx5. This raises the possibility that DCV
may derive membranes from other structures that are targets
for COPI-dependent vesicle formation or that DCV may in
some way redirect COPI to other sites. Possible explanations
for the source of COPI-mediated membrane recruitment
include the ER-intermediate compartment, as COPI has also
been localized to this area, or the possible anterograde
transport activity of the COPI coatamer. DCV, which is clearly
dependent on COPI for the generation of its virogenic
organelle and must in some way interdict normal COPI
trafﬁcking pathways, may prove to be a useful tool for
dissecting COPI functions and the complex relationships
between COPI, the Golgi, and the generation of vesicular
structures upon which viral replication occurs.
Under normal circumstances, in order to drive the
formation of COPI vesicles, the COPI coatamer complex is
bound by the small GTPase ADP-ribosylation factor 1 (Arf1).
These coatamer-GDP bound Arf1 complexes are activated by
guanine nucleotide exchange factors to induce vesicle
formation (reviewed in [37]). Our screen and additional
experiments did not identify Drosophila Arf1, nor any of the
other Arfs present in Drosophila, as being required for viral
replication. This may be due to some functional redundancy
between Arfs. Recent work on poliovirus demonstrated that a
number of different Arfs were recruited to the poliovirus
replication complexes [12]. Moreover, in a screen for factors
involved in general secretion in Drosophila cells, two Arfs were
essential [38]. Together, this may point to functional redun-
dancy of Arfs under certain conditions in a variety of systems.
Once we identiﬁed the COPI complex as necessary for
vesicle formation and Golgi maintenance, we reexamined the
additional factors identiﬁed during the initial screen and
found that suppression of fatty acid metabolism (SREBP and
CG3523) decreased viral replication in vitro and in vivo and
also prevented the formation of the vesicular compartment.
Thus, we were able to assign a functional role for fatty acid
metabolism in viral replication. This is perhaps not surprising
since morphometric analysis of membrane proﬁles in DCV-
infected cells indicated that there was a 2-fold increase in
membrane surface area within 10 h of infection. Thus, virus
infection leads to membrane redistribution involving both
the Golgi and COPI as well as membrane expansion through
de novo lipid biogenesis. Because the size of the virally
induced vesicles (mean¼115 nm) was signiﬁcantly larger than
that of normal COPI vesicles (mean ¼ 50 nm), they may be
formed in part by active membrane biosynthesis at the
budding site. Nevertheless, this coupling of fatty acid biosyn-
thesis with COPI coatamer budding from the Golgi results in
Golgi disassembly and the formation of a novel cytoplasmic
vesicular compartment upon which viral RNA replication
takes place.
More generally, it is not clear why it would be beneﬁcial for
a virus to generate a new membranous structure rather than
use preexisting membranes for replication. Indeed, some
viruses (e.g., ﬂock house virus) use preexisting membranes for
RNA replication instead of generating new structures [39].
Moreover, how viruses such as DCV coordinate and activate
these cellular processes has yet to be shown, making this
Drosophila-DCV system an ideal model both to identify cellular
factors required for viral replication and to study how virus-
dependent cellular structures and organelles are generated de
novo from preexisting components within a cell.
Importantly, the work presented herein conﬁrms the
relevance of the cell culture model used to perform the initial
RNAi screen by demonstrating a requirement in vivo for the
machinery which produces the virogenic organelle. Moreover,
we found that both COPI and fatty acid biosynthetic
machinery were essential for viral replication in adult animals.
This additional evidence supports the generality of the
ﬁndings and is the ﬁrst demonstration of the importance of
the virus-induced membranous organelle for infection of the
native host of a virus of this class. In addition, we extended our
ﬁnding to the related picornavirus, poliovirus. Using a similar
loss-of-function strategy in human cells, we found that, like
DCV infection of Drosophila cells, poliovirus infection of
human cells required COPI while COPII appeared dispen-
sable. Therefore, our screen for host factors in this Drosophila
model system provides insight into cellular genes required for
viral replication in higher organisms.
More work will be necessary to identify the mechanistic
aspects of vesicle formation and viral functions dependent
thereon. Nevertheless, our results form a basis for inves-
tigation of virus–host interactions, the limiting cellular
components required for the viral lifecycle, and potential
antiviral targets in a system that is amenable to both forward
and reverse genetic analysis and thus is uniquely suited to
rapid and comprehensive dissection.
Materials and Methods
Cells, antibodies, and reagents. SL2 cells, DL2 cells, and DeltaWT-
deMYC cells were grown and maintained as described previously
[13,26], as were the production and puriﬁcation of DCV [13].
Antibodies were obtained from the following sources: anti-DCV
[13], anti-Golgi (Calbiochem, San Diego, California, United States),
DG13 (anti-Golgi, gift of Vivek Malhotra, University of California San
Diego), anti-Delta (C594.9B, Iowa Hybridoma Bank, University of
Iowa, Iowa City, Iowa, United States), anti-tubulin (Sigma, St. Louis,
Missouri, United States), and anti-dSREBP (IgG 3B, prepared as
described [35]). Polyclonal anti-DCV helicase antibodies were
generated in rabbits against a peptide corresponding to residues
483–498 of the replicase polyprotein within the helicase domain.
Fluorescently labeled secondary antibodies against chicken were
obtained from Jackson ImmunoResearch (West Grove, Pennsylvania,
United States), and other secondary antibodies were from Molecular
Probes (Eugene, Oregon, United States). Additional chemicals were
obtained from Sigma.
RNAi. dsRNAs for RNAi were generated and used for RNAi for 3 d
as described [20]. Amplicons used were generated by the DRSC and
are described at http://ﬂyrnai.org.
Secretion assay. DeltaWTdeMYC cells were treated with dsRNA
and pulsed with 0.5 mM CuSO4 for 2 h. All subsequent steps were
performed at 4 8C. The cells were washed in FACS buffer (2% fetal
calf serum, azide, PBS) and stained with anti-Delta (1:200) for 45 min.
The cells were washed and stained with Alexa-488 anti-mouse for 45
min. Cells were analyzed on a FACScan ﬂow cytometer with Cell
Quest software (Becton-Dickinson, Palo Alto, California, United
States), live cells were gated using forward scatter and side scatter,
and propidium iodide was used to exclude dead cells.
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were performed as described [13]. Cells were pretreated with dsRNA
and placed at 4 8C. Virions were added (multiplicity of infection¼10)
and incubated for 2 h. The cells were washed and incubated at room
temperature for 3 h. Cells were then stained with anti-DCV as
described and counterstained with Alexa-594 phalloidin (Invitrogen,
Carlsbad, California, United States). For other experiments, cells were
infected and stained as previously described [20]. Cells were imaged
using automated microscopy [20] or confocal microscopy (Leica TCS
SP2 AOBS) as indicated, and percent infection was measured. Image
quantitation was performed using MetaMorph software (Molecular
Devices, Sunnyvale, California, United States).
Electron microscopy. Cells were ﬁxed on the dish in 2% PFA/2.5%
glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for 1 h at
RT, postﬁxed in 1% osmium tetroxide/1.5% potassium ferrocyanide
in water for 30 min, and stained in 1% uranyl acetate in maleate
buffer (pH 5.2) for 30 min at RT. After dehydration in a graded
ethanol series, cells were removed from the dish in propyleneoxide
and pelleted at 3,000 rpm for 3 min. Pellets were embedded in Epon.
Ultrathin sections (approximately 80 to 90 nm) were mounted on
copper grids, stained with 2% uranyl acetate in acetone followed by
0.2% lead citrate, and examined in a JEOL 1200EX transmission
electron microscope, and images were recorded at a primary
magniﬁcation of 39,700.
For preparation of cryosections, cells were ﬁxed in 4% parafor-
maldehyde (in 0.1 M sodium phosphate buffer [pH 7.4]) in a
microfuge tube and pelleted for 3 min at 3,000 rpm. The supernatant
was carefully removed, and fresh 4% paraformaldehyde was added.
After 2-h ﬁxation at room temperature, the cell pellets were washed
with PBS containing 0.2 M glycine. Cell pellets were inﬁltrated with
2.3 M sucrose in PBS for 15 min and frozen in liquid nitrogen. Frozen
samples were sectioned at  120 8C, transferred to formvar-carbon–
coated copper grids, and ﬂoated on PBS. Gold labeling was carried
out at room temperature on a piece of paraﬁlm. All antibodies and
Protein A-gold were diluted 1% BSA. Grids were ﬂoated on drops of
1% BSA for 10 min, transferred to 5-ll drops of primary antibody,
and incubated for 30 min. The grids were then washed in PBS for a
total of 15 min and transferred to drops of Protein A-gold or gold-
labeled secondary antibody. Embedding of the labeled grids was
carried out on ice in 0.3% uranyl acetate in 2% methyl cellulose. The
grids were examined in a JEOL 1200EX transmission electron
microscope, and images were recorded at a primary magniﬁcation
of 325,000 [40].
The total amount of membrane per cell was calculated by
measuring the linear amount of membrane of similar sized sections
of cells using MetaMorph software for uninfected (n¼6) and infected
(n ¼ 6) cells.
Fly stocks and viral infections. All ﬂies were obtained from the
Bloomington stock center unless stated otherwise and were main-
tained on standard medium at 24 8C. RU486-inducible Gal4 (S1106)
was used to rescue the larval lethality of the SREBP-null allele (189) by
feeding larvae 200 lM RU486 which induced the expression of the
UAS-SREBP rescue construct as described [36]. Following eclosion,
adults were maintained on standard medium. The 4- to 5-d-old adults
of the stated genotypes were inoculated with DCV as previously
described [13].
Immunoblotting and RT-PCR. Flies were collected at the time
points indicated. The ﬂies were lysed in radioimmunoprecipitation
buffer supplemented with a protease inhibitor cocktail (Boehringer-
Ingelheim, Ingelheim, Germany). Samples were separated by 10%
SDS-PAGE and blotted as previously described [13]. For RT-PCR, ﬂies
were lysed and total RNA was extracted using TRIzol (Invitrogen)
according to the manufacturer. cDNA was prepared using AMV
reverse transcriptase (Invitrogen) and the virus-speciﬁc primer DCV2
and used for PCR with the DCV1 and DCV2 primers as described [41].
Poliovirus experiments. Poliovirus Sabin 2 was a kind gift from the
Centers for Disease Control and Prevention (Atlanta, Georgia, United
States). Virus was expanded by growth in HeLa cells and concen-
trated by ultracentrifugation through a sucrose cushion, and titers
were determined by plaque assay on HeLa cells. For infections, Caco-
2 cells were cultured as described [42] and transfected with 10 nM
COPI, Sec23B, or control siRNAs (Dharmacon smart pools) using
HiPerFect transfection reagent according to the manufacturer’s
protocol (Qiagen, Valencia, California, United States). Transfected
cells were incubated with PV at a multiplicity of 1 PFU/cell in virus
binding buffer (DMEM supplemented with 1 mM HEPES for 1 h at 4
8C). Following washing, virus infection was initiated by shifting cells
to 37 8C in tissue culture medium for 7 h. Cells were ﬁxed and
permeabilized before staining with ice-cold methanol/acetone (3:1)
for 5 min at room temperature. Cells were incubated with FITC-
conjugated mouse anti-enterovirus VP1 (Ncl-Entero; Novocastra
Laboratories, Newcastle upon Tyne, United Kingdom) for 1 h,
w a s h e d ,a n dm o u n t e dw i t hV e c t a shield (Vector Laboratories,
Burlingame, California, United States) containing DAPI. Images were
captured with a confocal laser-scanning microscope (Leica, Exton,
Pennsylvania, United States). Plaque-forming assays were performed
in HeLa cells as described [42].
Statistical analysis. Statistical analyses for Figure 1 were performed
using the Fisher exact test for small samples; the v
2 test was used in
situations were all counts are above ﬁve. Student’s t-test was
performed on the data from Figure 6.
Supporting Information
Figure S1. RNAi against epsilonCOP and sec23 Leads to Depletion of
mRNA
RT-PCR of cells treated with the indicated dsRNA. Total RNA was
puriﬁed 3 d post treatment, used as a template for cDNA, and
ampliﬁed using primers speciﬁc for the indicated genes. The amount
of imput cDNA was varied to assess the linearity of the PCR
conditions.
Found at DOI: 10.1371/journal.ppat.0020102.sg001 (44 KB PDF).
Figure S2. DCV Replication Requires High Levels of COPI and Fatty
Acid Synthase in Adults
The ﬂies carrying a mutant allele of gammaCOP (gammaCop
[S057302a]) and fatty acid synthase AU: Make CG3523 italic? If so,
also gammaCOP(CG3523 [Df(2L)JS17]) are resistant to viral infection
as measured by viral antigen production post infection. Flies
heterozygous for each mutant or the compound mutants were
challenged with DCV, and viral antigen production was measured by
Western blot 24 h post infection. Protein lysates were generated and
probed with anti-DCV or anti-tubulin for normalization.
Found at DOI: 10.1371/journal.ppat.0020102.sg002 (16 KB PDF).
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